Sign In
test

Jose Santiago

Avidity Partners Management Lp

Assets Managed
$935.701M
Holdings
52
Last Quarter
2026 - Q1
Filed Date
18d ago
Growth Rate
169.9%(2Q avg: 74.4%)
Sustained Growth
1 quarters

Portfolio positions

This chart displays the top 10 holdings in Avidity Partners Management Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 52 positions.

Assets under management

The assets under management (AUM) of Avidity Partners Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 935.701M in assets, with a quarterly growth rate of 169.9% and a 2-quarter average growth rate of 74.4%. The portfolio is managed by Jose Santiago, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
DNTH
Dianthus Therapeutics Inc
Recent Activity
Increased 100%
38.62%
$361.33M
4.208M shares@ $85.86 avg price
ORKA
Oruka Therapeutics Inc
Recent Activity
Increased 130.29%
9.55%
$89.319M
1.521M shares@ $58.73 avg price
CGON
Cg Oncology Inc
Recent Activity
Decreased -12.47%
9.33%
$87.236M
1.289M shares@ $67.69 avg price
JBIO
Jade Biosciences Inc
Recent Activity
Increased 100%
5.76%
$53.857M
2.801M shares@ $19.23 avg price
CATX
Perspective Therapeutics Inc
Recent Activity
Increased 276.87%
5.22%
$48.823M
12.1M shares@ $4.04 avg price
ELVN
Enliven Therapeutics Inc
Recent Activity
Increased 470.21%
3.44%
$32.172M
800,000 shares@ $40.22 avg price
CNTX
Context Therapeutics Inc
Recent Activity
Increased 81.6%
2.67%
$24.891M
9.997M shares@ $2.5 avg price
TEVA
Teva Pharmaceutical-sp Adr
Recent Activity
Increased 55.79%
2.2%
$20.571M
650,100 shares@ $31.65 avg price
RGEN
Repligen Corp
Recent Activity
Increased 209.35%
1.97%
$18.371M
155,600 shares@ $118.07 avg price
PVLA
Palvella Therapeutics Inc
Recent Activity
Increased 625.39%
1.9%
$17.708M
140,000 shares@ $126.49 avg price

1-10 of 52